OST2PST Converter Software Acquired Appreciation For Comprehensive OST Data Recovery

India, March 31, 2012: The Company is happy to inform its users and readers about the positive feedback received by OST2PST converter software. PCVITA OST Recovery software is an excellent creation that is developed to cope up with issues related to OST file corruption in a simplified manner. OST file become unusable/orphaned or corrupted due to various reasons owing to which user lose accessibility over database stored in it and thus only eminent OST2PST converter software can help to retrieve the database. Appreciating Words by The User are as Follows: “Due to Server in cached mode, the organization was working in offline mode. When the connection with Exchange Server was established again, some of the employees were unable to synchronize their database. Such situation could have caused huge loss to the organization if we would not have deployed PCVITA OST Recovery software that helped us to recover and convert OST database to PST without much time consumption and effort utilization. Thanks to the intelligent and helpful team behind efficient OST2PST converter software.” Director of the Company, D.Pramanik says: “Client feedback acts as a mark sheet for us so that we can know about the progress rate of the software and how capably the software is performing its job to resolve problem of the users. We are happy to receive constructive feedback for our OST2PST converter software that we designed to repair corrupt OST file and convert recovered database to PST format of file. Client feedback, be it positive or demanding is welcome by us and we thank our user for their appreciating words for our PCVITA OST Recovery software that we developed for the purpose of helping users to convert OST to PST in case Server goes down or corruption strikes OST file leading to inaccessibility over emails, contacts, calendars, appointments and other email items.”

Suggested Articles

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.

In our EuroBiotech roundup this week, NEC and Vaximm ink cancer vaccine pact, Compugen posts cancer data and Lunac raises cash.

Biotech ATAI Life Sciences has partnered with artificial intelligence drug discovery specialist Cyclica to form a new JV.